ADVISORY, Jan. 13, 2017 --
What:
Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq:TCMD), a medical technology company that develops and provides innovative medical devices for the treatment of chronic diseases at home, will visit the Nasdaq MarketSite in Times Square.
In honor of the occasion, Gerald R. Mattys, Chief Executive Officer, will ring the Opening Bell.
Where:
Nasdaq MarketSite – 4 Times Square – 43rd & Broadway – Broadcast Studio
When:
Tuesday, January 17, 2017 – 9:15 a.m. to 9:30 a.m. ET
Tactile Medical Media Contact:
Kristen Weaver
(612) 355-5116
[email protected]
Nasdaq MarketSite:
Emily Pan
(646) 441-5120
[email protected]
Feed Information:
Fiber Line (Encompass Waterfront): 4463
Gal 3C/06C 95.05 degrees West
18 mhz Lower
DL 3811 Vertical
FEC 3/4
SR 13.235
DR 18.295411
MOD 4:2:0
DVBS QPSK
Social Media:
For multimedia features such as exclusive content, photo postings, status updates and video of bell ceremonies, please visit our Facebook page:
http://www.facebook.com/NASDAQ.
For photos from ceremonies and events, please visit our Instagram page:
http://instagram.com/nasdaq
For livestream of ceremonies and events, please visit our YouTube page:
http://www.youtube.com/nasdaq/live
For news tweets, please visit our Twitter page:
http://twitter.com/nasdaq
For exciting viral content and ceremony photos, please visit our Tumblr page:
http://nasdaq.tumblr.com/
Webcast:
A live stream of the Nasdaq Opening Bell will be available at:
https://new.livestream.com/nasdaq/live or http://www.nasdaq.com/about/marketsitetowervideo.asx
Photos:
To obtain a hi-resolution photograph of the Market Open, please go to http://business.nasdaq.com/discover/market-bell-ceremonies and click on the market open of your choice.
About Tactile Systems Technology, Inc.
Tactile Systems Technology, Inc. (“Tactile Medical”) is a medical technology company that develops and provides innovative medical devices for the treatment of chronic diseases at home. The Company is the sole manufacturer and distributor of the Flexitouch and Entré Systems, medical devices to help control symptoms of lymphedema, a chronic and progressive medical condition that is often an unintended consequence of cancer treatment, and the ACTitouch System, a medical device to treat venous leg ulcers and chronic venous insufficiency. The Company provides products for use both in the home and in health care institutions, including hospitals and vascular, wound and lymphedema clinics throughout the United States. For additional information, please visit http://www.tactilemedical.com. To receive future press releases via email, please visit Investors.tactilemedical.com.
About Nasdaq
Nasdaq (Nasdaq:NDAQ) is a leading provider of trading, clearing, exchange technology, listing, information and public company services across six continents. Through its diverse portfolio of solutions, Nasdaq enables customers to plan, optimize and execute their business vision with confidence, using proven technologies that provide transparency and insight for navigating today's global capital markets. As the creator of the world's first electronic stock market, its technology powers more than 70 marketplaces in 50 countries, and 1 in 10 of the world's securities transactions. Nasdaq is home to more than 3,700 listed companies with a market value of $10.0 trillion and approximately 18,000 corporate clients. To learn more, visit: nasdaq.com/ambition or business.nasdaq.com
-NDAQA-


TSMC Japan's Second Fab to Produce 3nm Chips by 2028
McDonald's and Restaurant Brands International Face Headwinds Amid Iran Conflict and Rising Costs
Apple Turns 50: From Garage Startup to AI Crossroads
SpaceX Eyes Historic IPO at $1.75 Trillion Valuation
Microsoft's $10 Billion Japan Investment: AI Infrastructure and Data Sovereignty Push
Luxury Car Sales in the Middle East Take a Hit Amid Iran War
UAE's Largest Natural Gas Facility Suspended After Attack-Triggered Fire
Nike Beats Q3 Estimates but China Weakness and Margin Pressure Weigh on Outlook
Russell 1000 Companies Hit $2.2T Cash Record While Aggressively Reinvesting in Growth
Private Credit Under Pressure: Is a Slow-Motion Crisis Unfolding?
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
Annie Altman Amends Sexual Abuse Lawsuit Against OpenAI CEO Sam Altman
Fonterra Admits Anchor Butter "Grass-Fed" Label Misled Consumers After Greenpeace Lawsuit
Tesla Q1 2026 Deliveries Miss Estimates as AI Strategy Takes Center Stage
CTOC Adds 3,000 Doctors, 500 Hospitals Ahead of Liquidity Push
MATCH Act Targets ASML and Chinese Chipmakers in New U.S. Export Crackdown
OpenAI Executive Shake-Up Ahead of Anticipated 2026 IPO 



